Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
暂无分享,去创建一个
S. Moncada | R. Palmer | R. Schulz | S. Moncada | D.D. Rees | R.M.J. Palmer | R. Schulz | H.F. Hodson | H. Hodson | D. Rees | D. Rees
[1] S. Moncada,et al. Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.
[2] S Moncada,et al. Role of endothelium-derived nitric oxide in the regulation of blood pressure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Moncada,et al. Characterization of the l‐arginine: nitric oxide pathway in human platelets , 1990, British journal of pharmacology.
[4] C. Nathan,et al. Identification of arginine as a precursor of endothelium-derived relaxing factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[5] S. Moncada,et al. A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation , 1989, British journal of pharmacology.
[6] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[7] A. J. Hobbs,et al. l‐NG‐monomethyl arginine and l‐NG‐nitro arginine inhibit non‐adrenergic, non‐cholinergic relaxation of the mouse anococcygeus muscle , 1990, British journal of pharmacology.
[8] J. Schrader,et al. Nitric oxide release from the isolated guinea pig heart. , 1988, European journal of pharmacology.
[9] S. Moncada,et al. The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.
[10] L. Ignarro,et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[11] L. Patthy,et al. Preparation and characterization of Ng-mono-, di- and trimethylated arginines. , 1977, Acta biochimica et biophysica; Academiae Scientiarum Hungaricae.
[12] S. Moncada,et al. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. , 1989, Biochemical and biophysical research communications.
[13] Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus. , 1988, European journal of pharmacology.
[14] Richard Graham Knowles,et al. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[15] Richard Graham Knowles,et al. Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. , 1989, Biochemical and biophysical research communications.
[16] P. López-Jaramillo,et al. The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.
[17] O. Griffith,et al. Evidence that L-arginine is the biosynthetic precursor of vascular and cardiac nitric oxide , 1990 .
[18] Y. Kobayashi,et al. Nitroarginine inhibits endothelium-derived relaxation. , 1990, Japanese journal of pharmacology.
[19] S. Moncada,et al. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. , 1988, Biochemical and biophysical research communications.
[20] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[21] S. Moncada,et al. EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.
[22] S. Moncada,et al. Nitric oxide synthesized from L‐arginine regulates vascular tone in the coronary circulation of the rabbit , 1989, British journal of pharmacology.
[23] S Moncada,et al. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. , 1989, Cardiovascular research.
[24] O. Griffith,et al. NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? , 1989, Biochemical and biophysical research communications.
[25] O. Griffith,et al. L-arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. , 1989, Biochemical and biophysical research communications.
[26] D. Pruess,et al. Antimetabolites produced by microorganisms. VI. L-N 5 -(1-iminoethyl) ornithine. , 1972, The Journal of antibiotics.
[27] A. Gibson,et al. l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro , 1990, British journal of pharmacology.
[28] J. Garthwaite,et al. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. , 1989, European journal of pharmacology.
[29] S. Moncada,et al. Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator , 1988, British journal of pharmacology.
[30] Kinetic characteristics of nitric oxide synthase from rat brain. , 1990, The Biochemical journal.
[31] B. Mayer,et al. Biosynthesis of endothelium-derived relaxing factor: a cytosolic enzyme in porcine aortic endothelial cells Ca2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. , 1989, Biochemical and biophysical research communications.
[32] W. H. Elliott,et al. Data for Biochemical Research , 1986 .
[33] J. Gillespie,et al. The effects of L‐arginine and NG‐monomethyl L‐arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation , 1989, British journal of pharmacology.